← Eichor
Study identifier: NCT07434479 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

Condition: Schizophrenia Disorder · Schizoaffecitve Disorder · Aggression  ·  Sponsor: Manhattan Psychiatric Center

PhaseNA
Planned participants58
Who can joinAll sexes, 18 Years to 64 Years
Healthy volunteersNo

About this study

The study investigates whether a virtual reality-based mindfulness based intervention can reduce impulsive aggression in individuals with schizophrenia or schizoaffective disorder. The primary goal is to evaluate whether mindfulness delivered via VR (MBI-VR) improves emotion regulation and engages the dorsomedial prefrontal cortex (dmPFC), a brain region involved in cognitive control and regulation of emotional responses. The study also examines whether these effects show a dose-related relationship. Participants will be randomized to receive different doses of MBI-VR intervention or distraction tasks and will complete repeated mindfulness VR sessions. Brain activity will be measured using functional magnetic resonance imaging (fMRI) during an emotion regulation task, along with clinical assessments of impulsive aggression related symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

Anzalee Khan, PhD  ·  646-766-5876  ·  anzalee.khan@nki.rfmh.org

Benedicto Parker  ·  212-961-8992  ·  Benedicto.Parker@nki.rfmh.org

Always discuss trial participation with your own doctor first.

Locations (2)

Manhattan Psychiatric CenterNew York, New York, United StatesRecruiting
NewYork-Presbyterian/Weill Cornell Medical Center Westchester DivisionWhite Plains, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07434479